SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations

Adriana Goncalves, Evren Karayel, Gillian I. Rice, Keiryn L. Bennett, Yanick J. Crow, Giulio Superti-Furga, Tilmann Bürckstümmer

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Aicardi-Goutières syndrome (AGS) is a rare inherited autoimmune disease caused by mutations in genes encoding the RNase H2 subunits A, B, and C; the DNase three prime repair exonuclease 1 (TREX1); and sterile alpha motif (SAM) domain and HD domain-containing protein 1 (SAMHD1). Using unbiased affinity purification coupled to protein mass spectrometry, we identify SAMHD1 as a nucleic-acid-binding protein displaying a preference for RNA over DNA. In contrast to TREX1 and the RNase H2 complex, SAMHD1 has no obvious nuclease activity. In addition, interrogating truncation mutants of SAMHD1 observed in AGS patients, we map the nucleic-acid-binding domain to residues 164-442, thus overlapping with the HD domain. Furthermore, we show that although wild-type SAMHD1 displays almost exclusive nuclear localization, 11 of 12 SAMHD1 mutants show at least partial mislocalization to the cytosol. Overall, these data suggest that SAMHD1 has a role in the nucleus that, if disrupted by mutation, leads to cytosolic accumulation of SAMHD1 and autoimmune disease. © 2012 Wiley-Liss, Inc.
    Original languageEnglish
    Pages (from-to)1116-1122
    Number of pages6
    JournalHuman Mutation
    Volume33
    Issue number7
    DOIs
    Publication statusPublished - Jul 2012

    Keywords

    • Aicardi-Goutières syndrome
    • Autoimmune disease
    • Innate immunity
    • SAMHD1

    Fingerprint

    Dive into the research topics of 'SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations'. Together they form a unique fingerprint.

    Cite this